Skip to content

Study of the Causes of the Breakdown of Muscle Fibers in Hospitalized Patients

Rhabdomyolysis - A Retrospective Study in Hospitalized Patients

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01022450
Enrollment
2500
Registered
2009-12-01
Start date
2009-11-30
Completion date
Unknown
Last updated
2009-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Renal Failure, Myopathy, Neuroleptic Malignant Syndrome, Rhabdomyolysis

Keywords

rhabdomyolysis, myopathy, acute renal failure, neuroleptic malignant syndrome, Pharmaceutical Preparations, Hydroxymethylglutaryl-CoA Reductase Inhibitors, fibrates, creatine kinase

Brief summary

1. Analyze the various causes of breakdown of muscle fibers in hospitalized patients. 2. Analyze the characteristics of these patients in Taiwan (including the drugs history, risk factors and the incidence of complications).

Detailed description

1. Find the causes of breakdown of muscle fibers in hospitalized patients through medical record review. * especially drug-related 2. Find the risk factors of muscle fibers breakdown.

Interventions

None listed

Sponsors

National Taiwan University Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patients who admitted to The National Taiwan University Hospital during 2003/1/1\ 2008/12/31 with the following discharge diagnosis: myoglobinuria, rhabdomyolysis, myopathy, toxic myopathy, malignant hyperthermia, neuroleptic malignant syndrome, polymyositis, myalgia and had acute neuromuscular illness presentations and serum creatinine kinase (CK) more than 5 times the upper limit of normal (male \> 900 IU/L; female \> 835 IU/L).

Exclusion criteria

* Patients with recent myocardial infarction or stroke, unless clinical history, examination, or electromyography showed a concomitant myopathy.

Countries

Taiwan

Contacts

Primary ContactFe-Lin L Wu, MSCP, PhD
flwu@ntu.edu.tw+886-2-23123456
Backup ContactKwan-Dun Wu, MD, PhD
kdwu@ntuh.gov.tw+886-2-23123456

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026